Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2021-12-13 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
安信证券股份有限公司关于公司子公司签署《关于盈康运城医院有限责任公司之委托管理协议》暨关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a sponsoring securities company regarding a related-party transaction involving a subsidiary of Yingkang Life Technology Co., Ltd. It discusses the signing of a management entrustment agreement, the nature of the transaction as a related-party transaction, approvals by the board and supervisory committee, and the compliance with relevant regulatory rules. The document includes detailed descriptions of the transaction, parties involved, financial data, and the sponsor's opinion on the transaction's compliance and fairness. It is not a financial report, earnings release, or regulatory filing per se, but rather a formal audit or verification opinion related to a specific transaction. This fits the definition of an Audit Report / Information (AR) as it is a standalone audit/verification report on a related-party transaction, including applied regulations and internal approvals, but not a full annual report or interim report. The document length (8636 characters) and content support this classification rather than a brief announcement or a general regulatory filing. FY 2021
2021-12-13 Chinese
独立董事关于第五届董事会第十八次（临时）会议相关事项的事前认可意见
Board/Management Information Classification · 95% confidence The document is a formal opinion from independent directors regarding specific matters to be discussed at a board meeting, including approval of related-party transactions and management agreements. It references compliance with company law, securities law, and stock exchange guidelines, and it is dated December 13, 2021. The content focuses on governance and board-level approvals rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial statements or earnings data, nor is it a notice of voting results or a proxy solicitation. The document is best classified as Board/Management Information (MANG) because it relates to board meeting matters and independent directors' opinions on corporate governance issues.
2021-12-13 Chinese
董事会战略与ESG委员会工作细则（2021年12月）
Governance Information Classification · 95% confidence The document is titled as the "Board Strategic and ESG Committee Work Rules" of 盈康生命科技股份有限公司, dated December 2021. It details the structure, responsibilities, membership, and procedures of a board committee focused on strategy and ESG (Environmental, Social, and Governance) matters. There are no financial statements, earnings data, or regulatory filings. The content is about governance practices and committee rules, which aligns with governance information. The document length is 4514 characters, which is substantive and not a brief announcement or certification. Therefore, it is best classified as Governance Information (CGR).
2021-12-13 Chinese
董事会议事规则（2021年12月）
Governance Information Classification · 100% confidence The document is titled as the "董事会议事规则" which translates to "Board Meeting Rules" or "Rules of Procedure for the Board of Directors" of 盈康生命科技股份有限公司. It details the composition, responsibilities, meeting procedures, committees, and governance structure of the company's board of directors. It references relevant laws and regulations such as the Company Law, Securities Law, and Shenzhen Stock Exchange rules. The content is focused on governance practices and internal board management rather than financial results, audit opinions, or shareholder meeting materials. It is not a report of financial performance, audit, or earnings, nor is it a notice or announcement. It is a governance document outlining the internal rules and structure of the board. Therefore, the appropriate classification is Governance Information (CGR). The document length (11565 characters) supports it being a full governance report rather than a brief announcement.
2021-12-13 Chinese
监事会议事规则(2021年12月）
Governance Information Classification · 100% confidence The document is titled as the "Rules of Procedure for the Supervisory Board" of 盈康生命科技股份有限公司, dated December 2021. It details the composition, powers, meeting procedures, decision-making, record-keeping, funding, and amendment rules of the Supervisory Board. It is a governance document outlining internal rules and procedures for the Supervisory Board, which is part of the company's corporate governance structure. There is no financial data, audit results, or report publication mentioned. It is not an announcement or a report but a governance framework document. Therefore, the document fits the category of Governance Information (CGR).
2021-12-13 Chinese
公司章程修订对照表
Governance Information Classification · 95% confidence The document is a detailed comparison table showing amendments to the company's Articles of Association (公司章程), including changes to board committees and governance structure. It mentions approval by the board and submission to a shareholders' meeting for approval. There is no financial data, no audit or financial report, no earnings information, no voting results, and no mention of a report being attached or published. The content focuses on governance structure and internal rules, specifically the board committees and their responsibilities, including the addition of an ESG committee. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2021-12-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.